| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| topiramate | Tablet, film coated | 25 mg | Resolved | Available | Manufacturing | 19/01/2026 |
| lamotrigine | Tablet, chewable | 200 mg | Anticipated | Available | Manufacturing | 19/01/2026 |
| levetiracetam | Tablet, film coated | 500 mg | Resolved | Available | Manufacturing | 19/01/2026 |
| pramipexole dihydrochloride monohydrate | Tablet | 1 mg | Current | Unavailable | Manufacturing | 19/01/2026 |
| ondansetron hydrochloride dihydrate | Tablet, film coated | 4.986 mg | Resolved | Available | Manufacturing | 19/01/2026 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Current | Unavailable | Manufacturing | 19/01/2026 |
| eplerenone | Tablet, film coated | 50 mg | Resolved | Available | Manufacturing | 19/01/2026 |
| eplerenone | Tablet, film coated | 25 mg | Resolved | Available | Manufacturing | 19/01/2026 |
| aprepitant | Capsule | 165 mg | Current | Limited Availability | Manufacturing | 19/01/2026 |
| lamotrigine | Tablet, chewable | 50 mg | Resolved | Available | Manufacturing | 19/01/2026 |
| ciprofloxacin hydrochloride | Tablet, film coated | 873.32 mg | Current | Unavailable | Manufacturing | 19/01/2026 |
| terbinafine hydrochloride | Tablet, uncoated | 281.25 mg | Current | Unavailable | Manufacturing | 16/01/2026 |
| salbutamol sulfate | Inhalation | 2.4 mg/mL | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 16/01/2026 |
| donepezil hydrochloride | Tablet, film coated | 5 mg | Resolved | Available | Manufacturing | 16/01/2026 |
| tacrolimus monohydrate | Capsule, hard | 5.112 mg | Resolved | Available | Manufacturing | 16/01/2026 |
| olanzapine | Tablet, orally disintegrating | 5 mg | Resolved | Available | Manufacturing | 16/01/2026 |
| valsartan~hydrochlorothiazide | Tablet, film coated | 160 mg~12.5 mg | Current | Limited Availability | Manufacturing | 16/01/2026 |
| temozolomide | Capsule, hard | 20 mg | Current | Unavailable | Manufacturing | 16/01/2026 |
| entecavir | Tablet, film coated | 1 mg | Current | Unavailable | Manufacturing | 16/01/2026 |
| fenofibrate | Tablet | 48 mg | Anticipated | Available | Manufacturing | 16/01/2026 |
| tobramycin | Inhalation, conventional | 60 mg/mL | Resolved | Available | Manufacturing | 16/01/2026 |
| fingolimod hydrochloride | Capsule | 560 microgram | Current | Unavailable | Manufacturing | 16/01/2026 |
| pentamidine isetionate | Injection, powder for | 300 mg | Resolved | Available | Manufacturing | 16/01/2026 |
| ketorolac trometamol | Injection, solution | 10 mg/mL | Current | Unavailable | Manufacturing | 16/01/2026 |
| lanreotide acetate | Injection, solution | 100 mg | Current | Unavailable | Manufacturing | 16/01/2026 |
| lanreotide acetate | Injection, solution | 66.67 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 16/01/2026 |
| nitrofurantoin | Capsule, hard | 100 mg | Current | Unavailable | Unexpected increase in consumer demand | 16/01/2026 |
| nitrofurantoin | Capsule, hard | 50 mg | Current | Limited Availability | Manufacturing | 16/01/2026 |
| hydrocortisone hydrogen succinate | Injection, powder for | 127.6 mg | Resolved | Available | Manufacturing | 16/01/2026 |
| amphotericin B | Injection, powder for | 50 mg | Resolved | Available | Manufacturing | 16/01/2026 |
| tetrabenazine | Tablet, uncoated | 25 mg | Resolved | Available | Manufacturing | 16/01/2026 |
| olipudase alfa | Injection, powder for | 20 mg | Anticipated | Available | Manufacturing | 16/01/2026 |
| olanzapine | Tablet, film coated | 5 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 16/01/2026 |
| atovaquone~proguanil hydrochloride | Tablet, film coated | 62.5 mg~25 mg | Anticipated | Available | Unexpected increase in consumer demand | 16/01/2026 |
| flumetasone pivalate~clioquinol | Ear Drops | .2 mg/mL~10 mg/mL | Anticipated | Available | Commercial Changes / Commercial viability | 15/01/2026 |
| bupivacaine hydrochloride | Injection, solution | 5 mg/mL | Current | Unavailable | Manufacturing | 15/01/2026 |
| propofol | Injection, intravenous infusion | 10 mg/mL | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 15/01/2026 |
| galantamine hydrobromide | Capsule, modified release | 10.256 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 15/01/2026 |
| temozolomide | Capsule, hard | 140 mg | Anticipated | Available | Manufacturing | 15/01/2026 |
| lansoprazole | Tablet, orally disintegrating | 15 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 15/01/2026 |
| amlodipine besilate~telmisartan | Tablet, film coated | 13.87 mg~40 mg | Current | Limited Availability | Unexpected increase in consumer demand | 15/01/2026 |
| telmisartan~amlodipine besilate | Tablet, film coated | 80 mg~6.935 mg | Current | Limited Availability | Unexpected increase in consumer demand | 15/01/2026 |
| telmisartan~amlodipine besilate | Tablet, film coated | 80 mg~13.87 mg | Current | Limited Availability | Unexpected increase in consumer demand | 15/01/2026 |
| amlodipine besilate~telmisartan | Tablet, film coated | 6.935 mg~40 mg | Current | Limited Availability | Unexpected increase in consumer demand | 15/01/2026 |
| isotretinoin | Capsule, soft | 20 mg | Current | Limited Availability | Manufacturing | 15/01/2026 |
| betahistine dihydrochloride | Tablet | 16 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 15/01/2026 |
| moxonidine | Tablet, film coated | 400 microgram | Current | Unavailable | Manufacturing | 15/01/2026 |
| agomelatinecitric acid | Tablet, film coated | 44.739 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 15/01/2026 |
| iopromide | Injection, solution | 768.86 mg/mL | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 15/01/2026 |
| paroxetine hydrochloride | Tablet, film coated | 22.22 mg | Resolved | Available | Manufacturing | 15/01/2026 |
| levothyroxine sodium | Tablet, uncoated | .1 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 15/01/2026 |
| tranexamic acid | Tablet, film coated | 500 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 15/01/2026 |
| isotretinoin | Capsule, soft | 20 mg | Current | Unavailable | Manufacturing | 15/01/2026 |
| framycetin sulfate | Eye and Ear Drops | 5 mg/mL | Current | Limited Availability | Manufacturing | 15/01/2026 |
| estradiol hemihydrate | Drug delivery system, transdermal | 3.09 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 15/01/2026 |
| dinoprostone | Gel | .3333 mg/g | Current | Unavailable | Manufacturing | 15/01/2026 |
| ambrisentan | Tablet, film coated | 5 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 14/01/2026 |
| olanzapine | Tablet, film coated | 5 mg | Current | Unavailable | Manufacturing | 14/01/2026 |
| calcium folinate hydrate | Tablet, uncoated | 18.6 mg | Current | Limited Availability | Unexpected increase in consumer demand | 14/01/2026 |
| carbidopa monohydrate~levodopa~entacapone | Tablet, film coated | 40.5 mg~150 mg~200 mg | Resolved | Available | Unexpected increase in consumer demand | 14/01/2026 |
| teriflunomide | Tablet, film coated | 14 mg | Current | Unavailable | Manufacturing | 14/01/2026 |
| posaconazole | Tablet, modified release | 100 mg | Current | Limited Availability | Manufacturing | 14/01/2026 |
| sitagliptin hydrochloride monohydrate~metformin hydrochloride | Tablet, modified release | 56.685 mg~1000 mg | Resolved | Available | Manufacturing | 14/01/2026 |
| prilocaine hydrochloride | Injection, solution | 100 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 14/01/2026 |
| varenicline tartrate~varenicline tartrate | Tablet, film coated | .855 mg~1.71 mg | Resolved | Available | Manufacturing | 14/01/2026 |
| metformin hydrochloride | Tablet, modified release | 1000 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 14/01/2026 |
| cytarabine | Injection, solution | 100 mg/mL | Anticipated | Available | Manufacturing | 14/01/2026 |
| desferrioxamine mesilate | Injection, powder for | 2 g | Current | Limited Availability | Manufacturing | 14/01/2026 |
| betiatide | Injection, powder for | 1 mg | Current | Unavailable | Manufacturing | 13/01/2026 |
| acetylcysteine | Injection, concentrated | 2 g | Current | Limited Availability | Manufacturing | 13/01/2026 |
| verapamil hydrochloride | Tablet, film coated | 240 mg | Resolved | Available | Manufacturing | 13/01/2026 |
| venlafaxine | Capsule, modified release | 75 mg | Current | Unavailable | Manufacturing | 13/01/2026 |
| ondansetron hydrochloride dihydrate | Injection, solution | 5 mg | Current | Unavailable | Manufacturing | 13/01/2026 |
| ondansetron hydrochloride dihydrate | Injection, solution | 10 mg | Current | Limited Availability | Manufacturing | 13/01/2026 |
| mycophenolate mofetil | Tablet, film coated | 500 mg | Resolved | Available | Manufacturing | 13/01/2026 |
| remifentanil hydrochloride | Injection, powder for | 1.097 mg | Resolved | Available | Manufacturing | 13/01/2026 |
| temozolomide | Capsule, hard | 5 mg | Current | Limited Availability | Manufacturing | 13/01/2026 |
| lansoprazole | Tablet, orally disintegrating | 30 mg | Current | Limited Availability | Manufacturing | 13/01/2026 |
| lansoprazole | Tablet, orally disintegrating | 15 mg | Current | Limited Availability | Commercial Changes / Commercial viability | 13/01/2026 |
| propofol | Injection, emulsion | 10 mg/mL | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 13/01/2026 |
| fentanyl citrate | Injection, solution | 785 microgram | Discontinued | Unavailable | Commercial Changes / Commercial viability | 13/01/2026 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Resolved | Available | Unexpected increase in consumer demand | 13/01/2026 |
| atomoxetine hydrochloride | Capsule, hard | 20.57 mg | Current | Unavailable | Manufacturing | 13/01/2026 |
| paracetamol | Injection | .5 g | Discontinued | Unavailable | Commercial Changes / Commercial viability | 13/01/2026 |
| paracetamol | Injection | .1 g | Discontinued | Unavailable | Commercial Changes / Commercial viability | 13/01/2026 |
| atorvastatin calcium trihydrate | Tablet, film coated | 43.38 mg | Current | Limited Availability | Manufacturing | 13/01/2026 |
| doxepin hydrochloride | Capsule, hard | 11.3 mg | Current | Unavailable | Manufacturing | 13/01/2026 |
| erlotinib hydrochloride | Tablet, film coated | 27.32 mg | Current | Unavailable | Unexpected increase in consumer demand | 13/01/2026 |
| atorvastatin calcium trihydrate | Tablet, film coated | 86.751 mg | Resolved | Available | Manufacturing | 13/01/2026 |
| prucalopride succinate | Tablet | 1.321 mg | Current | Unavailable | Manufacturing | 13/01/2026 |
| prucalopride succinate | Tablet | 2.642 mg | Current | Unavailable | Manufacturing | 13/01/2026 |
| Teriparatide | Injection, solution | 250 microgram/mL | Resolved | Available | Manufacturing | 13/01/2026 |
| doxepin hydrochloride | Capsule, hard | 28.25 mg | Current | Limited Availability | Manufacturing | 13/01/2026 |
| flunitrazepam | Tablet, film coated | 1 mg | Current | Unavailable | Manufacturing | 13/01/2026 |
| bupivacaine hydrochloride monohydrate | Injection, solution | 52.8 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 12/01/2026 |
| calcitonin salmon | Injection, solution | 100 IU/mL | Anticipated | Available | Unexpected increase in consumer demand | 12/01/2026 |
| dantrolene sodium hemiheptahydrate | Injection, powder for | 20 mg | Current | Emergency Supply Only | Manufacturing | 12/01/2026 |
| trimethoprim~sulfamethoxazole | Injection, concentrated | 16 mg/mL~80 mg/mL | Current | Unavailable | Manufacturing | 12/01/2026 |
| midazolam hydrochloride | Injection, solution | 5.56 mg/mL | Discontinued | Unavailable | Commercial Changes / Commercial viability | 12/01/2026 |
| tranexamic acid | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 12/01/2026 |
| erenumab | Injection, solution | 70 mg | Current | Limited Availability | Unexpected increase in consumer demand | 12/01/2026 |
| ambrisentan | Tablet, film coated | 5 mg | Resolved | Available | Manufacturing | 12/01/2026 |
| ambrisentan | Tablet, film coated | 10 mg | Resolved | Available | Manufacturing | 12/01/2026 |
| estradiol | Drug delivery system, transdermal | .39 mg | Current | Unavailable | Manufacturing | 12/01/2026 |
| estradiol | Drug delivery system, transdermal | .78 mg | Current | Unavailable | Manufacturing | 12/01/2026 |
| estradiol | Drug delivery system, transdermal | 1.17 mg | Current | Unavailable | Manufacturing | 12/01/2026 |
| estradiol | Drug delivery system, transdermal | 1.56 mg | Current | Unavailable | Manufacturing | 12/01/2026 |
| Teriparatide | Injection, solution | .25 mg/mL | Anticipated | Available | Manufacturing | 12/01/2026 |
| clindamycin phosphate | Cream | 22.8 mg/g | Anticipated | Available | Unexpected increase in consumer demand | 12/01/2026 |
| Peginterferon alfa2a | Injection, solution | 135 microgram | Current | Unavailable | Manufacturing | 12/01/2026 |
| Peginterferon alfa2a | Injection, solution | 180 microgram | Current | Unavailable | Manufacturing | 12/01/2026 |
| dinoprostone | Gel | .6667 mg/g | Current | Unavailable | Manufacturing | 12/01/2026 |
2026年1月19日